Taco Hemingway, the Polish rapper, is entangled in a legal issue after the Chief Pharmaceutical Inspectorate announced that the producer of the over-the-counter drug Solpadeine did not authorize the use of its name in his song 'Zakochałem się pod apteką'. This oversight could position Hemingway in a legal battle for unauthorized advertising of a medicinal product. The controversy gained traction in early February when the pharmaceutical community raised concerns about the implications of his song's popularity for public health and drug consumption.

In his song, which has become viral, Hemingway includes lyrics that reference purchasing Solpadeine, drawing attention to the medication. Solpadeine is a combination painkiller containing paracetamol, codeine, and caffeine. Although available without a prescription, it is critical to note that the drug should not be taken excessively or without medical guidance due to serious health risks, including potential liver damage and even death. The song has prompted fans to purchase Solpadeine more frequently, with many sharing photos and videos showing the drug, raising alarms about its misuse.

This situation not only highlights the intersection of pop culture and public health but also sets a precedent for how artists can interact with pharmaceutical branding in their work. As this matter unfolds, it poses questions about regulation in advertising, the responsibilities of artists when discussing drugs in their art, and the potential repercussions for both the artist and the pharmaceutical industry.